Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3491)
All Articles published online
|
Dec 21, 2012 (publication date) through May 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kim YJ, Sinn DH, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Tenofovir rescue therapy for chronic hepatitis B patients after multiple treatment failures. World J Gastroenterol 2012; 18(47): 6996-7002 [PMID: 23322999 DOI: 10.3748/wjg.v18.i47.6996] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i47/6996.htm |
| Number | Citing Articles |
| 1 |
Kwei‐Ming Chen, Chi‐Hsien Chang, Jyong‐Hong Lee, Chi‐Chieh Yang. Tenofovir disoproxil fumarate for patients with chronic hepatitis B who suboptimal response to non‐tenofovir disoproxil fumarate nucleos(t)ide analogs therapy. Advances in Digestive Medicine 2020; 7(4): 207 doi: 10.1002/aid2.13171
|
| 2 |
Giuseppe Coppolino, Mariadelina Simeoni, Chiara Summaria, Maria Concetta Postorino, Laura Rivoli, Alessio Strazzulla, Carlo Torti, Giorgio Fuiano. The case of chronic hepatitis B treatment with tenofovir: an update for nephrologists. Journal of Nephrology 2015; 28(4): 393 doi: 10.1007/s40620-015-0214-0
|
| 3 |
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn. Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response. Clinical and Molecular Hepatology 2020; 26(3): 352 doi: 10.3350/cmh.2019.0044n
|
| 4 |
Ki Bae Bang, Hong Joo Kim. Management of antiviral drug resistance in chronic hepatitis B. World Journal of Gastroenterology 2014; 20(33): 11641-11649 doi: 10.3748/wjg.v20.i33.11641
|
| 5 |
Joo Han Park, Seon Joo Ahn, Hyo Jung Cho, Soon Sun Kim, Jae Youn Cheong, Sung Won Cho. Clinical course of partial virological responders under prolonged entecavir monotherapy in patients with chronic hepatitis B. Journal of Medical Virology 2016; 88(2): 252 doi: 10.1002/jmv.24330
|
| 6 |
Fabien Zoulim, Jolanta Białkowska-Warzecha, Mircea Mihai Diculescu, Adrian Eugen Goldis, Renate Heyne, Tomasz Mach, Patrick Marcellin, Jörg Petersen, Krzysztof Simon, Soumaya Bendahmane, Isabelle Klauck, Wojciech Wasiak, Harry L. A. Janssen. Entecavir plus tenofovir combination therapy for chronic hepatitis B in patients with previous nucleos(t)ide treatment failure. Hepatology International 2016; 10(5): 779 doi: 10.1007/s12072-016-9737-2
|
| 7 |
Jung Gil Park, Soo Young Park. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy. Clinical and Molecular Hepatology 2015; 21(3): 242 doi: 10.3350/cmh.2015.21.3.242
|
| 8 |
Xieer Liang, Qing Xie, Jia Shang, Hong Tang, Min Xu, Qinghua Meng, Jiming Zhang, Pujun Gao, Jifang Sheng, Hao Wang, Jidong Jia, Guiqiang Wang, Shunquan Wu, Jingna Ping, Jinlin Hou. Tenofovir disoproxil fumarate for multiple nucleos(t)ide analogues treatment failure hepatitis B: Is monotherapy enough?. Journal of Gastroenterology and Hepatology 2022; 37(3): 471 doi: 10.1111/jgh.15757
|
| 9 |
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin. Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir. Clinical and Molecular Hepatology 2017; 23(3): 230 doi: 10.3350/cmh.2017.0003
|
| 10 |
Ae Rin Baek, Dae Yong Kim, Young Seok Kim, Sang Gyune Kim, Jung Hyun Kim, Min Suk Kim, Tae Jin Kim, Yun Nah Lee, Sae Hwan Lee, Soung Won Jeong, Jae Young Jang, Hong Soo Kim, Boo Sung Kim. Predictive Factors for Delayed Virologic Response of Adefovir Add-on Therapy in Lamivudine-resistant Chronic Hepatitis B. Soonchunhyang Medical Science 2013; 19(1): 10 doi: 10.15746/sms.13.003
|
| 11 |
Scott Fung, Stuart C. Gordon, Zahary Krastev, Andrzej Horban, Jörg Petersen, Jan Sperl, Edward Gane, Ira M. Jacobson, Leland J. Yee, Phillip Dinh, Eduardo B. Martins, John F. Flaherty, Kathryn M. Kitrinos, Geoffrey Dusheiko, Huy Trinh, Robert Flisiak, Vinod K. Rustgi, Maria Buti, Patrick Marcellin. Tenofovir disoproxil fumarate in Asian or Pacific Islander chronic hepatitis B patients with high viral load (≥ 9 log10 copies/ml). Liver International 2015; 35(2): 422 doi: 10.1111/liv.12694
|
| 12 |
Hyung Joon Yim, Seong Gyu Hwang. Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade. Clinical and Molecular Hepatology 2013; 19(3): 195 doi: 10.3350/cmh.2013.19.3.195
|
| 13 |
Hyo Jin Kim, Ju-Yeon Cho, Yu Jin Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee. Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients. The Korean Journal of Internal Medicine 2015; 30(1): 32 doi: 10.3904/kjim.2015.30.1.32
|
| 14 |
Yingxia Liu, Ying Zhang, Jing Yuan, Wen Zeng, Guoliang Zhang, Simin Yao, Huijuan Li, Min Yang, Yong Deng, Rongrong Zou, Shaxi Li, Jia Xiao. Efficacy of tenofovir disoproxil fumarate therapy in Chinese chronic hepatitis B patients after multiple antiviral failures. Hepatology Research 2015; 45(10) doi: 10.1111/hepr.12454
|
| 15 |
Dan-Hong Yang, Yuan-Jun Xie, Nian-Feng Zhao, Hong-Ying Pan, Ming-Wei Li, Hai-Jun Huang. Tenofovir disoproxil fumarate is superior to lamivudine plus adefovir in lamivudine-resistant chronic hepatitis B patients. World Journal of Gastroenterology 2015; 21(9): 2746-2753 doi: 10.3748/wjg.v21.i9.2746
|
| 16 |
Qian Zhang, Tao Han, Cai‐Yun Nie, Fu‐Shuang Ha, Lei Liu, Hua Liu. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures. Journal of Medical Virology 2015; 87(6): 1013 doi: 10.1002/jmv.24153
|
| 17 |
Woo Hee Cho, Hyun Jae Lee, Ki Bae Bang, Seok Bae Kim, Il Han Song. Development of tenofovir disoproxil fumarate resistance after complete viral suppression in a patient with treatment-naïve chronic hepatitis B: A case report and review of the literature. World Journal of Gastroenterology 2018; 24(17): 1919-1924 doi: 10.3748/wjg.v24.i17.1919
|
| 18 |
Jung-Ah Kang, Songwon Kim, Minji Park, Hyun-Jin Park, Jeong-Hyun Kim, Sanghyeok Park, Jeong-Ryul Hwang, Yong-Chul Kim, Yoon Jun Kim, Yuri Cho, Mi Sun Jin, Sung-Gyoo Park. Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-10200-5
|
| 19 |
Manjita Srivastava, Sumit Rungta, V.K. Dixit, S.K. Shukla, T.B. Singh, A.K. Jain. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: An Indian perspective. Antiviral Research 2013; 100(2): 300 doi: 10.1016/j.antiviral.2013.08.020
|